Hetero inks deal with MSD to manufacture Molnupiravir
By IANS |
2 Views
Hetero inks deal with MSD to manufacture Molnupiravir .. Image Source: IANS News
Hyderabad, April 27 : Hetero, one of India s leading generic pharmaceutical companies and the world s largest producer of anti-retroviral drugs, announced on Tuesday that it has entered into a non-exclusive voluntary licensing agreement with MSD for the manufacturing and distribution of investigational oral therapeutic antiviral drug Molnupiravir for treatment of Covid-19.
Under this licensing deal, Hetero will be allowed to expand access of Molnupiravir in India and in other low-and middle-income countries (LMICs), following the approvals for emergency use authorisation by local regulatory agencies.